When we learned about BBK’s effort to mobilize the DIA community in support of our hometown Boston and the One Fund, we immediately wanted to combine efforts to raise funds and rally other companies to do the same.
Norwood, MA (PRWEB) June 21, 2013
At the Drug Information Association (DIA) 49th Annual Meeting in Boston on June 23-27, BioPharm Insight™ by Infinata will raise support for The One Fund Boston and unveil a revolutionary new tool for forecasting the likelihood of drug approvals to over 7,000 conference attendees from the global pharmaceutical industry. Details regarding the forecasting feature will be publicly released during conference hours on June 24, 2013.
To raise awareness and support of the One Fund benefitting victims of the 2013 Boston Marathon bombing, BioPharm Insight has partnered with BBK Worldwide, a global leader in the patient recruitment industry, on BBK’s initiative to provide a method for attendees to get involved. For each attendee who sends a free text message of “Boston Strong” to 617.706.4000 during the meeting, Infinata and contributing companies including BBK Worldwide, ERT and Valesta Clinical Research will donate $5 to The One Fund Boston combining for a total contribution of up to $22,000.
“When we learned about BBK’s effort to mobilize the DIA community in support of our hometown Boston and the One Fund, we immediately wanted to combine efforts to raise funds and rally other companies to do the same,” said Kristopher E. Sarajian, director of marketing and public relations, Infinata, which publishes BioPharm Insight™ and BioPharm Clinical™. “With support from our parent company, Pearson plc, Infinata is pleased to match the $10,000 commitment demonstrated by BBK for this important cause.”
Attendees who send text messages from the BioPharm Insight booth will also receive “Strong at DIA” badge flags to further encourage their colleagues to do the same. Once the goal of $22,000 is achieved, attendees will be given the opportunity to donate on their own by going to http://www.OneFundBoston.org.
In addition, and because BioPharm Insight enables customers to stay ahead of their competition, visitors to the company’s exhibit booth (#1516) will receive a free pedometer. Whoever takes the most steps during the conference as recorded on the pedometer will be awarded an iPad Mini courtesy of Infinata.
About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com. Follow BioPharm Insight on LinkedIn and Twitter.
About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.